Press Releases

02.03.2015

Pfizer Receives U.S. FDA Accelerated Approval of IBRANCE® (palbociclib)

01.27.2015

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2014 RESULTS; PROVIDES 2015 FINANCIAL GUIDANCE

01.26.2015

Pfizer Commits to Further Reduce Price for Prevenar 13 in the World’s Poorest Countries Through 2025

01.26.2015

SANIONA RECEIVES A RESEARCH MILESTONE PAYMENT IN PFIZER INC. COLLABORATION

01.22.2015

Prevenar 13®* Receives CHMP Positive Opinion For Prevention Of Vaccine-Type Pneumococcal Pneumonia in Adults

01.21.2015

Pfizer and the Avon Foundation for Women Award 23 Grants Totaling $1 Million in Funding to Support Patients Living With Metastatic Breast Cancer

01.12.2015

HemoShear Announces Collaboration with Pfizer Inc. To Help Identify and Predict Drug-Induced Vascular Injury for Early Stage Compounds

01.12.2015

23andMe Announces Collaboration with Pfizer Inc. to Perform Genetic Research Through 23andMe’s Research Platform

01.08.2015

Repligen Receives Milestone Payment from Pfizer

01.08.2015

Pfizer Provides Update on IBRANCE® (palbociclib)

01.06.2015

Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference

01.05.2015

Pfizer Acquires Redvax GmbH